Loading...
* - Tentative Dates
The Company proposes to utilize the Net Proceeds towards the following objects:
| Period Ended | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 1,947.92 | 1,154.22 |
| Revenue | 4,062.79 | 509.84 |
| Profit After Tax | 32.73 | 5.43 |
| Amount in ₹ Crore | ||
Remedium Lifecare is a pharmaceutical company. The company offers trading and sale of APIs (KSMs and CRMs) and Intermediates in both the domestic and international markets.
The company offers broad portfolio of intermediates and active pharmaceutical ingredients (APIs) for different therapeutic use, i.e., Lisnopril for anti-hypertension, Domperidone, Pregabalin, Phenylephrine, Cetirizine dihydrochloride, etc.